Evaluation of the Safety and Efficacy of REBORN System for Lipolysis Treatment
NCT05507528
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
107
Enrollment
INDUSTRY
Sponsor class
Conditions
LIPOLYSIS
Interventions
DEVICE:
reborn treatment
Sponsor
Lightfective Ltd